India, Feb. 21 -- NIMHANS (National Institute of Mental Health and Neurosciences), a neuroscience institute in Bengaluru, has launched a first-of-its-kind Neuropathy Lecture Series to address the urgent need for better diagnosis and management of neuropathy. Developed by NIMHANS, this initiative will train primary care physicians nationwide through telemedicine-enabled interactive sessions, educational materials, and diagnostic tools. To drive the impact of this initiative, Jenburkt Pharmaceuticals has extended a supportive grant for the Neuropathy Lecture Series.

Neuropathy, or nerve damage, often remains undiagnosed or misdiagnosed, leading to chronic pain, disability, and diminished quality of life. Recognising this challenge, NIMHANS...